Spyre Therapeutics Inc. Common Stock vs Tractor Supply Co — how do they compare? Spyre Therapeutics Inc. Common Stock trades at $78.63 (market cap $7.52B), while Tractor Supply Co trades at $32.8 (market cap $17.56B). The key difference: Tractor Supply Co is far larger — about 2.3× Spyre Therapeutics Inc. Common Stock's market cap, and Tractor Supply Co pays a 2.85% dividend while Spyre Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Spyre Therapeutics Inc. Common Stock for 0 Days and Tractor Supply Co for 89 Days on average.
| SYRE | TSCO | |
|---|---|---|
Market Cap | $7.52B | $17.56B |
Volume | 1,441,031 | 9,523,235 |
Sector | Health | Consumer Cyclical |
52-Week High | $108.92 | $56.37 |
52-Week Low | $22.18 | $29.14 |
Typical Hold Time | 0 Days | 89 Days |
Enterprise Value | $6.52B | $23.87B |
Dividend Yield | — | 2.85% |
Signals from Pluang's Aura AI — not financial advice
SYRE trades at $80.45, down 6.34% over 24 hours, with technical indicators showing neutral momentum near key support at $79. The clinical-stage biotech shows no revenue but maintains strong analyst support (92% buy rating) with a $119.89 consensus target. Recent positive SPY003 phase II ulcerative colitis data (Zacks, 2026-09-09) and a $350 million public offering (GlobeNewsWire, 2026-10-05) provide catalysts, though financials reflect pre-revenue challenges with a -197.71% net margin.
Investment outlook balances high-risk, high-reward potential. The robust pipeline in inflammatory bowel disease offers substantial upside if clinical successes continue, but the absence of revenue, negative cash flow from operations, and reliance on financing pose significant risks. Near-term price action will hinge on Q3 2026 earnings and further clinical updates.
Tractor Supply (TSCO) trades at $32.74, down 2.12% today amid recent earnings misses. The stock shows mixed technical signals with bullish moving averages but neutral oscillators. Fundamentally, the company maintains solid profitability with 36.46% gross margins and 39.51% ROE, though revenue growth has slowed to 4.2% annually. Recent news highlights dividend sustainability concerns after two consecutive quarterly misses and a 17-year dividend growth streak.
Outlook remains cautious with analyst consensus at $36.76 target (12% upside) but recent institutional selling and earnings disappointments create near-term headwinds. Key risks include competitive pressures, rural consumer spending volatility, and margin compression from 7.66% to 6.42% over four years. The dividend yield of 0.73% provides income support while growth initiatives target pet care and logistics optimization.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Spyre Therapeutics develops extended half-life antibody therapies for inflammatory bowel disease, including ulcerative colitis and Crohn's disease. Its pipeline targets pathways such as α4β7, TL1A, and IL-23 with antibodies engineered for infrequent subcutaneous dosing and potential combination use.
Read more on SYRE →Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,016 of its namesake banners in 49 states and 178 Petsense stores. Stores are typically located in towns outside of urban areas and in rural communities. In fiscal 2021, revenue consisted primarily of livestock and pet (47%), hardware, tools, and truck (21%), and seasonal gift and toy (21%).
Read more on TSCO →